And again, it's very important that we educate the population. And when nurses are educated on the different subtypes of breast cancer, then we can also—we feel empowered. And now we can empower the ...

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...

Staying up to date with data from trials and information from organizations dedicated to cancer research is crucial for oncology nurses and APPs.

The FDA has accepted the resubmission of a BLA for odronextamab for the treatment of patients with relapsed/refractory ...

One of the hardest lessons learned occurred after I inadvertently failed at communication and education before transferring a ...

Oncology nurses and APPs play a key role in educating patients on BREAKWATER study findings and their impact on BRAF-mutant ...

Key opinion leaders explore approaches to dose modifications or treatment pauses due to side effects, including examples ...

How do you manage gastrointestinal side effects in patients on lorlatinib? Do you provide any preventive tips, and how does this compare to managing GI side effects from other ALK inhibitors?

Hazards of the LA wildfires necessitate awareness that first responders and those central to the fires may be at risk for ...